Home » Newsletters » BioWorld Science

BioWorld Science

July 11, 2022

View Archived Issues

Novel murine model of NASH-driven HCC developed

Researchers mimic human acute-on-chronic liver failure on rat

Potent capsid assembly modulators show promise in mouse model of HBV infection

Nanjing Shijiang Medicine Technology patents new compounds for cancer

H. Lundbeck A/S discloses new NMDA glycine-site receptor modulators

Novel momelotinib analogue shows promising preclinical efficacy as pan-JAK inhibitor

Gritscience Biopharmaceuticals describes new casein kinase inhibitors

RVX-201 shows protection against recurrent HSV-2 disease in guinea pig model

Aditxt reports promising safety profile of immunotherapeutic drug ADI-100

XuanZhu Pharma identifies new AhR antagonists

Sunshine Lake Pharma synthesizes new GTPase KRAS inhibitors

Discovery of novel gut-selective NaPi2b inhibitor with lower hydrophobicity and improved efficacy

Mcpip1 deletion model useful to study endothelial activation during chronic inflammation

Calpain inhibitor BLD-3051 shows promising results in preclinical liver fibrosis

Vaccines targeting MICA/B designed for efficacy against tumors resistant to cytotoxic T cells

Condensates cross disease states, study finds

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...